Cerylid and the Peter MacCallum Cancer Institute have set up a collaboration to look for new anti-cancer drug leads, using Cerylid's natural products library as a source. [ + ]

IBM has forged a multimillion dollar research pact with the Institute for Molecular Bioscience (IMB) which promises a great leap forward for Australia's bioinformatics sector. [ + ]

A new technique for fingerprinting DNA from a single cell may have tremendous potential for forensic investigations and other applications, allowing individuals to be identified from just one cell. [ + ]

An embarrassing oversight has forced a listed company controlled by self-styled "corporate rationaliser" Farooq Khan to lift its takeover offer for biotech Biota Holdings. [ + ]

When you think of the Human Genome Project, images of banks of sequencing machines pumping out millions of base pairs of information comes to mind. According to Dr John Barlow, Melbourne divisional manager of the Australian Genome Research Facility, state-of-the-art sequencing is still largely electrophoresis-based. However, sequencers have come a long way since the days of pouring your own sequencing gel and using radioactive dideoxynucleotides. [ + ]

Microarray technology is now a major tool available to the geneticist. The technology allows researchers to look at the expression of a vast array of genes simultaneously, and myriad applications have been found in the last few years. But deciding on the best microarray system for the needs of the research is a difficult task, with several choices available. [ + ]

'Victorians: Bright Ideas, Brilliant Future' -- a new innovation statement from the Victorian government announcing $310 million in new funding for science, technology and research initiatives -- was today launched by State Premier Steve Bracks and Innovation Minister John Brumby. [ + ]

Medica Holdings has raised $3.25 million in a private placement to leading Australian institutional investors. [ + ]

The annual competition for research grants from the National Health and Medical Research Council (NHMRC) has been fought and and won -- and 406 projects have won the prestigious, peer-reviewed right to share in this year's funding pool of $150 million. [ + ]

Peptech's share price plunged more than 50 per cent today after announcing that it had ceased receiving European royalties from US-based Centocor. [ + ]

Melbourne biotechnology company Metabolic Pharmaceuticals has engaged Adelaide biotech BresaGen to develop a scaleable production system for its promising anti-obesity compound AOD9604. [ + ]

A Sydney briefing last week on the global bioinformatics market was told that Australia must boost its record on science spending or risk falling behind the so-called 'Asian tiger' economies of its neighbours. [ + ]

Melbourne biotech company Meditech Research has launched a $3.5 million capital raising, underwritten by Intersuisse, to fund initial Phase II clinical trials of its HyACT anti-cancer treatments. [ + ]

Dendritic Nanotechnologies (DNT), a subsidiary of Melbourne organisation Starpharma, has received $US3.5 million ($6.3 million) from the United States government to establish facilities for applied dendrimer research and development at Central Michigan University (CMU). [ + ]

A business plan for a new testing device designed to improve the lives of thousands of people each year struck down with lung disease has scooped the top prize worth $25,000 in this year’s Royal Melbourne Institute of Technology Business Plan Competition.